Grant: Research Tools and Instruments
Université de Montréal
$128,240.00
Sound-Induced 3D Biofabrication and Morphogenesis
EF 2022-23
Résumé
We propose purchasing a unique acoustic bioprinter, CymatiXT (mimiX biotherapeutics, Switzerland, the only vendor of this technology). Sound-induced 3D biofabrication and morphogenesis is a gentle, fast, and easy method to generate multi-cellular, spatially orchestrated tissue constructs using sound waves. This innovative technology provides prospects to overcome some major limitations of conventional methods towards the creation of physiologically relevant in vitro models and engineered tissue constructs. The uniqueness of this technology will push the frontiers of 3D biofabrication both in fundamental and applied research. The requested instrument will uniquely support and complement the mission of our innovative research program to 1) formulate, characterize and validate novel bioinks for 3D bioprinting of human pluripotent stem cell-derived tissues; 2) develop tissue-engineered models using cutting-edge 3D bioprinting and human pluripotent stem cell technologies; 3) transform the drug development process by providing tissue-engineered 3D models capable of faithfully recapitulating the hallmarks of human physiology and disease in vitro. It also supports the vision of our program to produce and validate engineered tissues and organs for replacement and as 3D models for drug safety and efficacy testing. The instrument will be installed at the Research Center of the Sainte Justine Hospital (CRCHUSJ). This will enable all interested users in the CRCHUSJ and University of Montreal to have access to the instrument, which will generate significant interdisciplinary collaborative works. The 3D bioprinter will be used by trainees (HQP) of the applicants and users to acquire hands-on training that will provide them with the marketable skills required for jobs in their disciplines. The 3D bioprinter and team members' laboratories will become attraction poles for highly motivated and qualified students and researchers in biomedical engineering. By acquiring this 3D bioprinter, our innovative program will revolutionize tissue engineering and organ bioprinting and have the spectacular potential for future global leadership in tissue manufacturing. It will also generate social, health, and economic benefits for Canadians, including enhanced training and improved skills for highly qualified personnel. The benefits of this program will be realized by technology transfer activities, intellectual property licensing, creation of new start-up companies, and collaboration with our partners, including the National Research Council of Canada, Montreal TransMedTech Institute, Axelys, and MEDTEQ+, among others.
Programme
Research Tools and Instruments
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RTI-2022-00539
Name nom
Savoji, Houman
Department département
Génie biomédical, Institut de - Génie biomédical, Institut de
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2022
Award amount
128240
Program id
RTI
Program name en
Research Tools and Instruments
Program name fr
Outils et instruments de recherche
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1602
Committee name en
Biological Systems and Functions (RTI)
Committee name fr
Systèmes et fonctions biologiques (OIR)
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Installment
inst:1
Partie
1
Nb partie
1
Application title
Sound-Induced 3D Biofabrication and Morphogenesis
Application summary
We propose purchasing a unique acoustic bioprinter, CymatiXT (mimiX biotherapeutics, Switzerland, the only vendor of this technology). Sound-induced 3D biofabrication and morphogenesis is a gentle, fast, and easy method to generate multi-cellular, spatially orchestrated tissue constructs using sound waves. This innovative technology provides prospects to overcome some major limitations of conventional methods towards the creation of physiologically relevant in vitro models and engineered tissue constructs. The uniqueness of this technology will push the frontiers of 3D biofabrication both in fundamental and applied research. The requested instrument will uniquely support and complement the mission of our innovative research program to 1) formulate, characterize and validate novel bioinks for 3D bioprinting of human pluripotent stem cell-derived tissues; 2) develop tissue-engineered models using cutting-edge 3D bioprinting and human pluripotent stem cell technologies; 3) transform the drug development process by providing tissue-engineered 3D models capable of faithfully recapitulating the hallmarks of human physiology and disease in vitro. It also supports the vision of our program to produce and validate engineered tissues and organs for replacement and as 3D models for drug safety and efficacy testing. The instrument will be installed at the Research Center of the Sainte Justine Hospital (CRCHUSJ). This will enable all interested users in the CRCHUSJ and University of Montreal to have access to the instrument, which will generate significant interdisciplinary collaborative works. The 3D bioprinter will be used by trainees (HQP) of the applicants and users to acquire hands-on training that will provide them with the marketable skills required for jobs in their disciplines. The 3D bioprinter and team members' laboratories will become attraction poles for highly motivated and qualified students and researchers in biomedical engineering. By acquiring this 3D bioprinter, our innovative program will revolutionize tissue engineering and organ bioprinting and have the spectacular potential for future global leadership in tissue manufacturing. It will also generate social, health, and economic benefits for Canadians, including enhanced training and improved skills for highly qualified personnel. The benefits of this program will be realized by technology transfer activities, intellectual property licensing, creation of new start-up companies, and collaboration with our partners, including the National Research Council of Canada, Montreal TransMedTech Institute, Axelys, and MEDTEQ+, among others.